Brief: Sonnet Biotherapeutics Holdings Inc - QTRLY Loss Per Share $0.31

Sonnet Biotherapeutics Holdings

14/02/2024 13:37

Feb 14 (Reuters) - Sonnet Biotherapeutics Holdings Inc
 SONN.O :
    * QTRLY LOSS PER SHARE $0.31
    * AS OF DECEMBER 31, 2023, SONNET HAD $3.0 MILLION CASH ON
HAND
AND NO DEBT

Source text for Eikon:  ID:n0001493152-24-006314 
Further company coverage:  SONN.O 

 ((Reuters.Briefs@thomsonreuters.com;))